Optimizing DC vaccination by combination with cytokine-expressing oncolytic adenoviruses

被引：0
|
作者：
Yun, Chae-Ok [1 ]
机构：
[1] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea
来源：
JOURNAL OF GENE MEDICINE | 2014年 / 16卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
S2-4
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [31] Oncolytic viruses: Potential for in situ anti-tumor vaccination and combination with checkpoint blockade
    Melcher, Alan
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [32] Cellular Delivery of Oncolytic Adenoviruses Utilizing Mesenchymal Stromal Cells (MSCs) in Combination with CAR-T Cell Therapy
    McKenna, Katie
    Englisch, Alexander
    Smith, Tyler
    Hoyos, Valentina
    Suzuki, Masataka
    Brenner, Malcolm K.
    MOLECULAR THERAPY, 2020, 28 (04) : 210 - 211
  • [33] Esophageal Cancer Treatment Using an Interferon-Expressing Oncolytic Adenovirus in Combination with Chemotherapy and Radiation
    LaRocca, Christopher J.
    Oliveira, Amanda R.
    Davydova, Julia
    Yamamoto, Masato
    MOLECULAR THERAPY, 2014, 22 : S253 - S253
  • [34] Oncolytic Transcriptionally Retargeted Adenovirus Expressing Nitroreductase in Combination with Antiangiogenic Drug RAD001
    Lukashev, Alexander N.
    Homicsko, Krizstian G.
    Fuerer, Cristophe
    Iggo, Richard
    MOLECULAR THERAPY, 2006, 13 : S246 - S246
  • [35] Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model
    Poutou, J.
    Bunuales, M.
    Gonzalez-Aparicio, M.
    Garcia-Aragoncillo, E.
    Quetglas, J. I.
    Casado, R.
    Bravo-Perez, C.
    Alzuguren, P.
    Hernandez-Alcoceba, R.
    GENE THERAPY, 2015, 22 (09) : 696 - 706
  • [36] Safety and Antitumor Effect of Oncolytic and Helper-Dependent Adenoviruses Expressing Interleukin-12 Variants in a Hamster Pancreatic Cancer Model
    Poutou, Joanna
    Bunuales, Maria
    Gonzalez, Manuela
    Garcia-Aragoncillo, Eva
    Quetglas, Jose I.
    Casado, Raquel
    Bravo-Perez, Carlos
    Alzuguren, Pilar
    Hernandez-Alcoceba, Ruben
    MOLECULAR THERAPY, 2015, 23 : S46 - S46
  • [37] In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2
    Liu, Weilin
    Dai, Enyong
    Liu, Zuqiang
    Ma, Congrong
    Guo, Zong Sheng
    Bartlett, David L.
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 17 : 350 - 360
  • [38] Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model
    J Poutou
    M Bunuales
    M Gonzalez-Aparicio
    E Garcia-Aragoncillo
    J I Quetglas
    R Casado
    C Bravo-Perez
    P Alzuguren
    R Hernandez-Alcoceba
    Gene Therapy, 2015, 22 : 696 - 706
  • [39] Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids
    Geissler, M
    Gesien, A
    Tokushige, K
    Wands, JR
    JOURNAL OF IMMUNOLOGY, 1997, 158 (03): : 1231 - 1237
  • [40] Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses
    Watanabe, Keisuke
    Luo, Yanping
    Da, Tong
    Guedan, Sonia
    Ruella, Marco
    Scholler, John
    Keith, Brian
    Young, Regina M.
    Engels, Boris
    Sorsa, Suvi
    Siurala, Mikko
    Havunen, Riikka
    Tahtinen, Siri
    Hemminki, Akseli
    June, Carl H.
    JCI INSIGHT, 2018, 3 (07)
12345